In Brief: Quidel/Ansell correction
This article was originally published in The Gray Sheet
Executive Summary
Quidel/Ansell correction: In a release announcing Quidel's distribution and marketing agreement with Ansell Consumer Products ("The Gray Sheet" Nov. 20, I&W-7), Ansell incorrectly stated that the three Quidel pregnancy tests involved in the agreement -- Conceive, Q-Test, and RapidVue -- would be sold under Ansell's Lifestyles brand with coupons for Lifestyles condoms. In fact, only the RapidVue test will be sold under the Lifestyles name with coupons...
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.